IL10 and inflammatory bowel disease: Genome-wide association studies have identified polymorphisms in IL10 and IL10R genes, both associated with early onset of IBD, more severe disease, and lack of response to standard treatments, including anti-tumour necrosis factor (TNF) biologic therapy (12, 13).